Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 23,164 | 18,350 | 26,487 | 25,215 | 23,521 |
| Cost of Goods | 9,778 | 9,971 | 9,867 | 9,939 | 11,405 |
| Gross Profit | 13,386 | 8,379 | 16,620 | 15,276 | 12,116 |
| Operating Expenses | 25,248 | 30,935 | 26,926 | 27,766 | 31,763 |
| Operating Income | -11,084 | -21,585 | -9,439 | -11,551 | -19,242 |
| Interest Expense | 2,606 | 2,612 | 2,293 | 2,239 | 2,175 |
| Other Income | 588 | 776 | 908 | 889 | 632 |
| Pre-tax Income | -13,102 | -23,421 | -10,824 | -12,901 | -20,785 |
| Income Tax | 47 | 63 | -22 | 15 | 18 |
| Net Income Continuous | -13,149 | -23,484 | -10,802 | -12,916 | -20,803 |
| Net Income | $-13,149 | $-23,484 | $-10,802 | $-12,916 | $-20,803 |
| EPS Basic Total Ops | -0.27 | -0.48 | -0.17 | -0.26 | -0.51 |
| EPS Basic Continuous Ops | -0.27 | -0.48 | -0.16 | -0.26 | -0.51 |
| EPS Diluted Total Ops | -0.27 | -0.48 | -0.17 | -0.26 | -0.51 |
| EPS Diluted Continuous Ops | -0.27 | -0.48 | -0.16 | -0.26 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.35 | -0.22 | -0.26 | -0.51 |
| EBITDA(a) | $-9,158 | $-19,534 | $-7,333 | $-8,975 | $-17,155 |